Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
13 hedge funds and large institutions have $587K invested in Guardion Health Sciences, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
63% more funds holding
Funds holding: 8 → 13 (+5)
6% more capital invested
Capital invested by funds: $556K → $587K (+$31K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.4K |
| 3 |
BlackRock
New York
|
+$58.3K |
| 4 |
Bank of New York Mellon
New York
|
+$28.6K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$7.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$439K |
| 2 |
Barclays
London,
United Kingdom
|
-$38.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$22.1K |
| 4 |
HF
HRT Financial
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $249K | +$178K | +1,685 | +1,204% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $125K | +$97.4K | +921 | New |
|
|
3
BlackRock
New York
| $81K | +$58.3K | +551 | +1,281% |
|
|
4
Barclays
London,
United Kingdom
| $46K | -$38.7K | -366 | -52% |
|
|
5
Bank of New York Mellon
New York
| $37K | +$28.6K | +270 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $14K | -$22.1K | -209 | -68% |
|
|
PMG
7
Private Management Group
Irvine,
California
| $12K | – | – | – |
|
|
8
Victory Capital Management
San Antonio,
Texas
| $10K | +$7.83K | +74 | New |
|
9
Citadel Advisors
Miami,
Florida
| $6K | +$4.55K | +43 | New |
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $6K | +$4.55K | +43 | New |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$740 | +7 | New |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| – | -$439K | -6,646 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$2K | -35 | Closed |
|
14
Wells Fargo
San Francisco,
California
| – | +$106 | +1 | New |
|
|
PFO
15
Pathstone Family Office
Englewood,
New Jersey
| – | +$211 | +2 | New |
|
GHSI Hedge Fund Activity: Q1 2020 in Review
13 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q1 2020, worth a combined $587K — up 5.6% from $556K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GHSI positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $178K. The largest seller was Sabby Management, exiting entirely with an estimated $439K sold.
- 13 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q1 2020, up from 8 in Q4 2019.
- Funds reported $587K of Guardion Health Sciences, Inc. Common Stock stock for Q1 2020, up 5.6% quarter-over-quarter.
- 8 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q1 2020 and 2 closed out, a net change of +6 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q1 2020 was Vanguard Group, an estimated $178K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q1 2020 was Sabby Management, an estimated $439K sold.
Based on aggregated 13F filings for Q1 2020.